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Endothelial nitric oxide synthase (eNOS) is inhibited by hydrogen peroxide (H2O2), but the mechanism has not
been determined. Thus, the purpose of this study was to delineate the mechanism by which H2O2 inhibits eNOS
activity. Using mass spectroscopy, we found that the tetrathiolate cysteine residues 94 and 99 were susceptible to
oxidation by H2O2. Molecular modeling predicted that these cysteic acid modifications would disrupt the van der
Waals interactions and the hydrogen bonding network mediated by the tetrathiolate cysteines 94 and 99 resulting
in changes in quaternary structure, zinc release, and dimer collapse. Using recombinant human eNOS (heNOS) to
test the predictions of the molecular modeling we found that H2O2 caused disruption of the heNOS dimer and this
was accompanied by zinc release and decreased NO generation. We also found that H2O2 increased the oxidation
of tetrahydrobiopterin (BH4) to dihydrobiopterin (BH2), whereas preincubation of heNOS with excess BH4 pre-
vented the destruction of zinc tetrathiolate and dimer collapse and preserved activity. Interestingly, we found that
the dimmer-stabilizing effect of BH4 is due to its ability to act as a catalase mimetic. Further, we confirmed that, in
ovine aortic endothelial cells, H2O2 could also induce dimer collapse and that increasing cellular BH4 levels could
maintain eNOS in its dimeric form and NO signaling when cells were challenged with H2O2. This study links the
inhibitory action of H2O2 on heNOS through the destruction of zinc tetrathiolate metal-binding site and dimer
collapse both in vitro and in vivo.
Introduction
Vascular endothelial cells produce nitric oxide (NO),which is an important signaling molecule in the regu-
lation of vascular tone and platelet aggregation. NO is syn-
thesized as a by-product during oxidation of l-arginine to
l-citrulline by the enzyme NO synthase (NOS). Three iso-
forms of NOS exist, two constitutively active forms are found
in endothelial cells (eNOS) and neurons (nNOS) and an in-
ducible form is found in macrophages (iNOS). NO is a major
endothelium-derived relaxing factor of the arterial circula-
tion. Thus any perturbation on the synthesis of NO can have
significant effects on blood pressure, flow, and vascular re-
sistance (Knowles, 1996).
Endothelial dysfunction is a hallmark of many diseases of
the vasculature including pulmonary and systemic hyper-
tension, atherosclerosis, and diabetes (Griendling et al., 2000a,
2000b). Oxidative stress and reactive oxygen species (ROS) are
thought to play amajor role in the development of endothelial
dysfunction (Lubos et al., 2008; Munzel et al., 2008). Hydrogen
peroxide (H2O2) is a nonradical ROS that can contribute to
overall oxidative stress. It is primarily produced from super-
oxide anion by superoxide dismutase. Among all ROS spe-
cies, H2O2 presents the lowest reduction potential, greatest
half-life, and highest intracellular concentration and does not
react with NO (Giorgio et al., 2007). H2O2 is a membrane-
permeable molecule that can act as a signaling molecule be-
cause of its intrinsic ability to induce fully reversible protein
modifications. H2O2 can directly oxidize cysteine residues to
sulphenic acids and induce glutathionylation of cysteine res-
idues or sulphoxidation of methionine residues in several
cellular targets (Forman et al., 2004). Previous studies indicate
that exogenous NO exposure inhibits eNOS activity (Sheehy
et al., 1998; Black et al., 1999). The molecular mechanism
proposed was through S-nitrosylation of cysteines 94 and 99.
This modification causes the disruption of zinc tetrathiolate
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metal-binding site, dimer collapse, and loss of enzymatic ac-
tivity (Ravi et al., 2004). In addition, it has been demonstrated
that increases in intracellular H2O2 concentration induced by
nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase activation can inhibit both eNOS expression and activity
(Wedgwood and Black, 2005). Based on all these data, we hy-
pothesized that molecular mechanism bywhich H2O2 inhibits
eNOS activity could involve, at least in part, dimer collapse.
In this study,we investigated themolecular effects on eNOS
activity and dimeric structure, through a model of an acute
oxidant stress exerted byH2O2 challenge.Our results describe,
for the first time, that this inhibitory phenomenon involves the
oxidation of tetrahydrobiopterin (BH4) and cysteine residues
94 and 99 within the zinc metal-binding site of eNOS. These
oxidative reactions lead to eNOS dimer collapse, zinc release,
and impairment of NO generation both in vitro and in vivo.
Our data also suggest that BH4, by virtue of its antioxidant ca-
pacity, prevents the oxidation of the zinc tetrathiolate metal-
binding site andmaintains the eNOS dimer.We speculate that
eNOS monomerization may be a general inhibitory mecha-
nism in conditions of high oxidative and nitrosative stress.
Materials and Methods
Chemicals
l-Arginine, flavin adenine dinucleotide (FAD), NADPH,
calmodulin, Dowex 50W-X8, phenyl methyl sulfonyl fluo-
ride, pepstatin A, leupeptin, protease inhibitor cocktail, 4-(2-
pyridyl (azo) resorcinol) (PAR), standard molecular weight
markers for gel filtration, S-nitroso N-acetyl penicillamine, N-
acetyl penicillamine, ethylenediaminetetraacetic acid, and
ethylene glycol tetraacetic acid (EGTA) were purchased from
Sigma (St. Louis,MO);Ni-NTAresin fromNovagen (Carlsbad,
CA); calmodulin sepharose, adenosine diphosphate (ADP)-
sepharose, and l-[2,3,4,5-3H] arginine from Amersham-
Pharmacia Biotech (Piscataway, NJ); monoclonal antibodies
against eNOS from Transduction Laboratories (Franklin
Lakes, NJ); Luria Broth (LB) and Scintiverse II from Fisher
(Pittsburg, PA); Isopropyl b-D-1-thiogalactopyranoside
(IPTG) from Life Technologies (Carlsbad, CA); BL21(DE3)-
pLysS from Novagen; western blotting and Coomassie
staining reagents from Pierce (Rockford, IL); BioSpin P-30
Tris columns from BioRad (Hercules, CA); modified trypsin
from Promega (Madison, WI); and disposable minicolumns,
Chelex-100, and Bradford reagent for protein determination
from BioRad. The poly-His-pCWeNOS vector was a gift
from P.R. Ortiz de Montellano (University of California, San
Francisco). BH4 was obtained from Schirck’s Lab ( Jona,
Switzerland), and unless otherwise mentioned all other
chemicals were purchased from Sigma.
Expression and purification of wild-type human eNOS
Protein expression and purification were performed as
previously described by Ravi et al. (2004). The recombinant
human eNOS (heNOS) protein was purified to 95% with a
yield of *20–30mg=8L of culture.
Oxidation with H2O2 and proteolytic digest
of recombinant heNOS
One hundred microliters of heNOS (*0.8 mg=mL) was
passed through a BioSpin column preequilibrated with HEN
buffer (250mM HEPES [pH 7.7], 1mM ethylenediaminete-
traacetic acid, 0.1mM neocuproine) to remove dithiotlreitol
(DTT). Zinc was added to the protein in the molar ratio of 2:1
(protein:Zn). Then H2O2 was added to bring the final con-
centration to 50mM and incubated for 30min at 378C. The
sample was centrifuged again with Biospin column to re-
move excess peroxide and 200mL of 8M urea and 0.4M
ammonium bicarbonate (pH 7.5) were added. To reduce the
disulfide bonds, 50mL of 45mM DTT was added to the sam-
ple and incubated at 508C for 15min. After bringing the
sample to room temperature, 50 mL of 100mM iodoaceta-
mide was added and left in the dark for 15min. The sample
was diluted to 2M urea and 0.1M ammonium bicarbonate
by adding water. Twenty microliters of trypsin (0.1 mg=mL)
was added and incubated at 378C overnight. Digestion was
stopped by freezing and then the sample was lyophilized.
For subsequent AspN protease digest, 20 mL of 15 ng=mL
AspN in 50mM ammonium bicarbonate was added to the
sample after resuspending the sample in 100mL of 50mM
ammonium bicarbonate buffer. The sample was left to digest
overnight at 378C. The digest was dried and resuspended in
water for mass spectral analysis.
Nano-liquid chromatography–mass
spectroscopy=mass spectroscopic analysis
Samples were desalted online on a C18 trap and then eluted
across a C18 column into the mass spectrometer. The samples
were desalted for 10minwith 100% solvent A and then turned
to next column at gradient of 5–60% solvent B for 40min.
Solvent A consisted of 100%water with 0.1% formic acid, and
solvent B was 80% acetonitrile (ACN) and 0.1% formic acid in
water. Flow rate was 250 nL=min. ThermoElectron LTQ lin-
ear ion trap mass spectrometer (ThermoElectron, San Jose,
CA) equipped with a nanospray ionization source with a
10 cm75 mm C18-packed nanospray tip was used. The sta-
tionary phase was Biobasic C18, 3-mm particles.
Molecular modeling
The zinc tetrathiolate coordination model was obtained
using the Discovery Studio (DS) 2.1 (Accelrys, San Diego, CA)
software package. Van der Waals interactions and hydrogen
bonds (H-bonds) were measured. The three-dimensional
crystallographic structure of eNOS was obtained from the
Research Collaboratory for Structural Bioinformatics (RCSB)
protein data bank (PDB) accession code 3NOS (humandimeric
eNOS with arginine substrate, oxidoreductase domain chains
A and B) (Fischmann et al., 1999). The Ramachandran imper-
fections and missing loops were fixed using Modeller Prepare
Protein 37 from DS 2.1. This function prepares any given
protein for molecular simulations. This function is composed
of five steps: (1) build loops (type¼BoolType) that determine
if missing loops are being inserted based on SEQRES data; (2)
use looper; (3) use modeller; (4) use CHARMmminimization,
and (5) usemaximal loop length. Themaximal loop length step
used was of long type. The prepare protein of DS 2.1 also has
a protonate step that determines whether or not to protonate
the final structure with the protein ionization method. The
protonation is based on protein dielectric constant analysis
and calculations of pH for protonation. The protein dielectric
constant specifies the dielectric constant of the protein interior.
The function pH for protonation specifies the proper pH value
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to protonate the molecule. The force field utilized by the pre-
pare protein function was of STRINGTYPE, and this specifies
the force field to be used for matrix calculations (CHARMm,
CHAMPLR, CHARMm19, CHARMm22, andCHARMm27).
In addition, this method also utilizes a prepare protein struc-
ture function that cleans up common problems in the input
protein structure in preparation for further processing by other
protocols. Finally, we submitted the prepared 3NOS PDB
file to a standard dynamics simulation cascade. This standard
dynamics simulation cascade is composed of six steps: (1) the
prepared 3NOS PDB file is typed into the DS 2.1 software
using the CHARMm force field; (2) a first step of minimization
using steepest descent algorithm, using a total of 5000 steps,
root mean square (RMS) gradient of 0.001, and no constraints;
(3) followed by a second step of minimization using the
adopted basis non relatavistic (NR) as an algorithm, using a
total of 5000 steps, RMS gradient of 0.001, and no constraints;
(4) heating step: parameters are 5000 steps, time step 0.001,
initial temperature 50.08F, target temperature 300.08F, and no
constraints; (5) an equilibration step: parameters are 10,000
steps with a time step of 0.001, target temperature 300.08F,
no constraints, constant pressure: false, PMass¼ 1000.0,
PGamma¼ 25, and reference pressure 1.0; and finally, (6) a
production step consisting of 10,000 steps, time step 0.001,
target temperature 300.08F, temperature coupling decay
time¼ 5.0, no constraints, type¼ constant volume constant
temperature ensemble (NVT), TMass¼ 1000.0, implicit sol-
vent model¼ generalized born with simple switching (best
algorithm in the world), nonbond list radius¼ 14, nonbond
higher cutoff distance¼ 12, nonbond lower cutoff dis-
tance¼ 10, electrostatics¼ spherical cutoff, Kappa¼ 0.34, or-
der¼ 4, dynamics integrator¼ leapfrog verlet, apply SHAKE
constraint¼ false, and random number seed¼ 314159. Fi-
nally, after running the molecular dynamics simulation with
CHARMm force field, the H-bonds and Van der Waals in-
teractions were monitored by DS 2.1. This gave us the wild-
type (WT) 3NOS PDB file (Fig. 1A) ready for cysteic acid
modification. After the last two steps, we performed cysteic
acid modification on the tetrathiolate cysteines 94 and 99.
We then performed another molecular dynamic simulation
on this modified file (using the same parameters described),
monitored the H-bonds and Van der Waals interactions by
DS 2.1, and generated Figure 1B. This figure illustrates the
potential effects of a cysteic acid modification on the ZnS4
center.
Treatment of purified heNOS with H2O2
Fractions of DTT-free purified heNOS (2 mg) were incu-
bated with the reaction mixture containing H2O2 (0–100mM)
for 30min at 378C for the citrulline conversion assay and
then the heNOS dimer content was determined using either
low-temperature polyacrylamide gel electrophoresis (LT-
PAGE) (Ravi et al., 2004) or gel filtration analysis (see below).
For gel filtration analysis, 100 mg of DTT-free pure heNOS
was incubated with or without BH4 (100mM) on ice for 1 h,
followed by removal of unbound BH4 by buffer exchange
(Vivaspin 20 100,000 MWCO PES; Satorius, Goettingen,
Germany). heNOS was treated with H2O2 (100 mM) at 378C
for 30min, and the dimeric state was analyzed by fast pro-
tein liquid chromatography (FPLC), using UV fluorescence
detection.
Assay for heNOS activity
This assay was performed by measuring the formation of
[3H]citrulline from [3H]arginine, with 10mM l-arginine as
substrate as initially described (Hevel and Marletta, 1994)
using our published modifications (Ravi et al., 2004).
Zinc release by PAR assay
Zinc release was measured by PAR assay as initially de-
scribed (Hevel and Marletta, 1994) using our published
modifications (Ravi et al., 2004). All buffers were pretreated
with Chelex-100 to remove residual zinc. heNOS was also
FIG. 1. Molecular modeling of the zinc tetrathiolate metal-
binding site in heNOS. (A) The model shows that cysteines
94 and 99 from each chain are directly involved in four in-
tramolecular van der Waals interactions that are involved in
the maintenance of the zinc tetrahedral atomic coordination
with the cysteines 94 and 99. The cysteines 94 and 99 also
appear to be involved in a network of eight H-bonds with
residues N466, G101, and L100. Together these bonds
maintain the symmetrical coordination of the C94 and C99
residues. (B) The effect of oxidation of cysteines 94 and 99
leading to drastic changes in the quaternary structure of the
zinc tetrathiolate coordination due to the disruption of all
van der Waals interactions and alterations within the H-
bond network. These alterations will disrupt zinc coordina-
tion. heNOS, human endothelial nitric oxide synthase.
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purified in buffers treated with Chelex-100. DTT-free puri-
fied heNOS protein (1–1.5mg) was treated with H2O2
(100 mM) for 30min in a reaction volume of 200 mL at room
temperature in the dark, in the presence or absence of 100mM
BH4. The reaction mixture was added to a cuvette containing
150 mM PAR in 50mM Tris-Cl and 100mM NaCl (pH 7.8) in
a total volume of 1mL. The reaction was mixed well and the
spectra were recorded from 300 to 600 nm. heNOS protein
alone was used to calibrate the spectrophotometer.
Quantification of BH4 levels
DTT-free pure heNOS was preincubated with or without
BH4 (50mM) in ice for 1 h, followed by removal of unbound
BH4 by buffer exchange using Centricon. The heNOS protein
was treated with H2O2 (10mM) at 378C for 30min. After this,
the spent buffer and theheNOSproteinwere analyzed for BH4=
dihydrobiopterin (BH2) content byHPLCequippedwith afluo-
rescence detector. The HPLC detection was performed using
differential oxidation methods of Fukushima and Nixon (1980)
using our published modifications (Wainwright et al., 2005).
LT-PAGE
LT-PAGE was carried out according to the procedure of
Klatt et al. (1995) with our published modification (Ravi et al.,
2004). Subsequent to LT-PAGE, gels were transferred to
Hybond-ECL nitrocellulose membrane in 20% methanol,
25mM Tris HCl (pH 8.3), and 192mM glycine. Western
blotting was carried out according to our standard proce-
dures (Hallmark et al., 1999) with mouse anti-eNOS antibody
(Transduction Labs). Bands were quantified by densitometric
scanning using a Kodak Image station (Carestream Health,
Rochester, NY) as previously described (Brennan et al., 2003).
Gel filtration chromatography
Gel filtration chromatography was carried out at 48C using
a Superose 6 HR10=30 column and an FPLC system (Amer-
sham-Pharmacia Biotech). The column was equilibrated with
40mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid
(EPPS) (pH 7.6), 5%glycerol, and 150mMNaCl. Typically pure
heNOS protein (100mg) in 200mL sample volume was injected
and the column effluentwasmonitored at 280 nmusing a flow-
through UV detector. The column was calibrated with Mr
standards: carbonic anhydrase (29 kDa), bovine serum albu-
min (66kDa), alcohol dehydrogenase from yeast (150kDa), a-
amylase from sweet potato (200kDa), apoferritin from horse
spleen (443 kDa), andbovine thyroglobulin (669 kDa). The void
volume of the column was determined using blue dextran.
H2O2 dismutation assay
H2O2 dismutation was determined using a modification of
the method of Aebi (1984). To estimate the ability of BH4 to
dismutate H2O2, a solution of 10mM H2O2 in 50mM po-
tassium phosphate buffer (pH 7.8) in the presence or absence
of 14mM of BH4 was analyzed for the disappearance of H2O2.
Absorbance was determined at 240 nm (for 30 s) in a spec-
trophotometer (BioSpec-1601; Shimadzu, Columbia, MD).
Cell culture
Primary cultures of ovine pulmonary arterial endothelial
cells (PAECs) were isolated and cultured as previously de-
scribed (Wedgwood and Black, 2005). The cells were incu-
bated overnight in serum-free Dulbecco’s modified Eagle’s
medium with 1 g=L glucose. In certain studies, cells were
preincubated for 18 h with sepiapterin (100 mM) in the pres-
ence or absence of the sepiapterin reductase inhibitor N-
acetylserotonin (NAS) (100mM). The cells were then treated
for 15min with H2O2 and were exposed or not to shear stress
for 5min at 20 dyn=cm2 prior to harvest for LT-PAGE anal-
ysis. The cells were harvested by scraping into phosphate-
bufferedsalineandsonicated todisrupt thecellularmembrane.
Protein was determined using the Bradford assay. PAECs
between passages 4 and 6 were used.
Shear stress
Laminar shear stress was applied using a cone-plate vis-
cometer that accepts six-well tissue culture plates, as previ-
ously described (Sud et al., 2007). This method achieves
laminar flow rates that represent physiological levels of
laminar shear stress in the major human arteries, which is in
the range of 5–20 dyn=cm2 (Lin et al., 1997), with localized
increases to 30–100 dyn=cm2.
Detection of NOx
NO generated by PAECs in response to shear stress was
measured using an NO-sensitive electrode with a 2-mm-
diameter tip connected to an Apollo 4000 Free-Radical
Analyzer (ISO-NOP, WPI, Sarasota, FL), as previously de-
scribed (Sud et al., 2007).
Statistical analysis
Quantitation of all western blots was performed using a
Kodak Image station 440CF and theKDS1D imaging software.
The mean standard deviation of the densitometric data
was calculated. The mean standard deviation was also
calculated for all eNOS activities. In all cases, comparisons
between treatment groups were made using either the
unpaired t-test or the analysis of variance with posttest
Newman–Kuehls using the Prism software program. A
p-value of <0.05 was considered statistically significant.
Results
H2O2 oxidizes cysteine residues in heNOS
to cysteic acid
To investigate the molecular mechanism by which H2O2
interacts and inhibits heNOS, we first employed a mass
spectroscopic (MS) approach. Cysteine residues can be con-
verted to cysteic acid in the presence of mild oxidizing agents
such as H2O2. This reaction produces a mass shift of 48 Da in
peptides containing these modified cysteines. The results
from our mass spectra (Table 1) show that the cysteines 94
and 99 (residues involved in the formation of zinc coordi-
nation) are oxidized. MS=MS spectrum of the doubly
charged ion at m=z 1372.5 was also obtained. The spectrum
identifies the oxidation of cysteine 94 to cysteic acid. Simi-
larly, two other peptides confirmed the presence of oxidized
cysteines 94 and 99. These peptides appear at m=z 1253.3
(þ3) and at m=z 1217.7 (þ3) which shows the oxidation of
cysteine 99. In addition to the cysteines 94 and 99 residues,
we found other oxidized cysteines. Table 1 lists all the pep-
tides containing cysteic acid modifications that were detected
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by nano-liquid chromatography–MS=MS (positions of cys-
teines: 14, 25, 273, 367, 380, 710, 990, 1104, and 1113).
Molecular modeling of wild-type heNOS
Next, we utilizedmolecular modeling to analyze the effects
of cysteic acid modification induced by H2O2 on the overall
quaternary structure of heNOS. The zinc metal is tetrahe-
drally coordinated by two pairs of symmetrically related
cysteine residues from each subunit (Fig. 1A; cysteines 94
and 99). This zinc tetrathiolate metal-binding site is located at
the bottom of the dimer interface (Crane et al., 1998; Fisch-
mann et al., 1999). The sulfur atoms in cysteine 94 (from each
subunit) have a van der Waals radius of 2.2 A˚ from the zinc
atom. Accordingly, the sulfur atoms of cysteine 99 have a
van der Waals radius of 2.4 A˚. In addition, the cysteines 94
and 99 are involved in a network of eight H-bonds with the
amino acids: L100, two H-bonds of 2.4 A˚ each with C94;
G101, two H-bonds of 2.4 A˚ each with C99; N466, two H-
bonds of 1.7 A˚ each with C99; and N466, two H-bonds of
2.1 A˚ each with C99. Based on these molecular modeling
measurements, the cysteic acid modification potentially
causes the disruption of several crucial H-bonds and four
van derWaals interactions that are predicted to lead to drastic
quaternary structural changes. These changes would in turn
culminate with the collapse of the zinc tetrathiolate metal-
binding site, zinc release, and monomerization (Fig. 1B).
H2O2 treatment decreases NO production
by dimer collapse
To test the molecular modeling prediction we initially
carried out a series of in vitro experiments using purified
recombinant heNOS protein. Our model predicts how H2O2
can inhibit heNOS through a mechanism of dimer collapse
mediated, at least in part, by cysteic acid modifications
within the tetrathiolate metal-binding site. Based on these
predictions, we next evaluated the effect of H2O2 on heNOS
dimer levels. To accomplish this, we initially used LT-PAGE
and western blotting analysis and examined the direct oxi-
dation effect of H2O2 on the dimeric state of heNOS. H2O2
concentrations in range of hundreds of micromolars have
been reported to be generally associated with the consump-
tion of common beverages or smoking (Halliwell et al., 2000).
Thus, based on these studies we incubated purified heNOS
with pathophysiological concentrations of H2O2 ranging
from 0 to 500mM. The results obtained demonstrate that
H2O2 induces a concentration-dependent shift in the level of
the functional dimeric form to the inactive monomeric form
(Fig. 2A, B). Further, gel filtration analysis confirmed that
when heNOS was treated with H2O2 (100mM) there was
complete monomerization of the enzyme (Fig. 2C). Our data
show that H2O2 (100mM) significantly inhibits heNOS ac-
tivity as measured by the conversion of [3H]-l-arginine to
[3H]-l-citrulline (Fig. 2D).
H2O2 disrupts the zinc tetrathiolate metal-binding
site and oxidizes BH4
To further validate the MS data and the molecular mod-
eling mechanistic prediction, we analyzed the effect of H2O2
on the integrity of zinc coordination at the dimer interface
using the PAR assay. Our results indicate that zinc was re-
leased when purified heNOS was exposed to H2O2 (100mM),
as determined by the increase in absorbance of the PAR-
bound zinc emission peak at 500 nm (Fig. 3). These data
couple dimer collapse with the disruption of the zinc tetra-
thiolate metal-binding site. During l-arginine hydroxylation,
BH4 acts as a one-electron donor and then it is reduced back
to BH4 within eNOS flavoprotein domain, in a calmodulin-
dependent manner (Wei et al., 2008). In addition, the BH4
molecule is involved in a H-bonding network that stabilizes
the NOS dimer (Raman et al., 1998). Therefore, we next ex-
amined the effect induced by H2O2 on the heNOS cofactor
BH4, to further explore the molecular mechanism for the
heNOS dimer collapse. Interestingly, when we analyzed the
BH4 content of the purified recombinant heNOS after H2O2
treatment we found it to be predominantly the oxidized BH2
form (Fig. 4). These data suggest that H2O2 may exert its
inhibitory effect on heNOS activity by the simultaneous ox-
idation of the cysteine residues 94 and 99 and the cofactor
BH4. These oxidation events lead to heNOS dimer collapse
and diminished rate of l-arginine hydroxylation (one limit-
ing step in the l-arginine=citrulline conversion).
Increased BH4 levels prevent dimer collapse
and loss of activity
Dimerization and dimer maintenance appear to be de-
pendent on the presence of zinc, heme, and BH4 cofactors, as
Table 1. List of Digested Peptides of Human Endothelial Nitric Oxide Synthase Showing Mass Shift
Due to Formation of Cysteic Acid on Reacting with Hydrogen Peroxide
Peptide detected M, z Sequence of the peptide Position of cysteic acid modification
3528.0 Da, 3 LAAEVHRVLCaLERGHMFVCaGDVTMATNVLQT 1104 and 1113
2791.0 Da, 3 QAACbETFCaVGEDAKAAARDIFSPKR 710
3653.2 Da, 3 GPCaTPRRCaLGSLVFPRKLQGRPSPGPPAPEQLLS 93 and 98
2512.7 Da, 3 YRQQDGSVRGDPANVEITELCaI 273
3493.8 Da, 3 GTRNLCaDPHRYNILEDVAVCaMDLDTRTTSS 367 and 380
2012.3 Da, 3 KSVAQEPGPPCaGLGLGLGLGL 14
3462.9 Da, 3 LKSVAQEPGPPCGLGLGLGLGLCaGKQGPATPAPEPSR 25
2563.9 Da, 2 GPPCbGLGLGLGLGLCaGKQGPATPAPEP 25
3296.9 Da, 3 QLKPGDPVPCaFIRGAPSFRLPPDPSLPCIL 990
3760.2 Da, 3 EVGSITYDTLSAQAQQDGPCTPRRCaLGSLVFPRK 98
2745.9 Da, 2 EVGSITYDTLSAQAQQDGPCaTPRRC 93
aRepresents cysteic acid formation (mass shift: 48 Da).
bRepresents carbamidomethylation (mass shift: 57 Da).
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FIG. 2. H2O2-mediated inhibition of purified heNOS
in vitro. The effect of H2O2 (0–500mM) on purified heNOS
protein (2 mg) dimer levels were measured using LT-PAGE
and western blot analysis. (A) A representative western blot
is shown demonstrating that H2O2 dose dependently de-
creases the level of active heNOS dimers. (B) The bar graph
shows that the dimeric level of heNOS dimer decreased dose
dependently after H2O2 treatment. Gel filtration analysis of
purified heNOS (100mg) exposed or not to 100mM of H2O2
was also carried out to confirm the LT-PAGE data. heNOS is
a mixture of dimer and monomer (80:20 ratio); however,
H2O2 treatment induces full monomerization. (C) Re-
presentative gel filtration chromatograms from three inde-
pendent experiments. (D) The effect of H2O2 (100mM) on the
ability of heNOS to metabolize [3H]-l-arginine to [3H]-l-
citrulline was also determined. The presence of H2O2 in the
reaction mixture results in a 60% inhibition in NOS activity.
Values are mean SD from three experiments. *p< 0.05
versus untreated, {p< 0.05 versus previous concentration of
H2O2. H2O2, hydrogen peroxide; LT-PAGE, low-temperature
polyacrylamide gel electrophoresis; SD, standard deviation.
FIG. 3. H2O2 induces release of zinc from heNOS. Purified
heNOS (1mg) was treated with and without H2O2 (100mM)
in the presence or absence of BH4 (100 mM) for 30min at 378C
(in the dark) in a cuvette containing PAR (150mM). A cuvette
containing only heNOS was used to autozero the spectro-
photometer. Absorbance scan spectra were recorded be-
tween 300 and 600 nm. Shown is a representative recording
from three independent experiments. H2O2 causes a release
of zinc from the heNOS dimer that was prevented by the
presence of excess BH4. BH4, tetrahydrobiopterin; PAR, 4-(2-
pyridyl (azo) resorcinol).
FIG. 4. H2O2 exposure oxidizes bound BH4 in recombinant
heNOS. DTT-free pure heNOS (100 mg) was incubated with
BH4 (50mM), unbound BH4 was removed, and heNOS was
treated with H2O2 (10mM) at 378C for 30min. The levels of
total BH4 and BH2 bound to the protein were determined.
Results were expressed as fmol=mg protein SD. n¼ 3.
*p< 0.05 versus untreated.
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well the substrate l-arginine. Therefore, we next preincubated
purified heNOS with BH4, followed by treatment with the
highest pathophysiological concentration of H2O2, to deter-
mine whether increasing BH4 levels could prevent the heNOS
dimer collapse induced by H2O2. We then analyzed the pro-
tein samples by gel filtration chromatography. These gel fil-
tration data suggest that purified WT heNOS exists as a
mixture of dimeric (80%) and monomeric (20%) forms, and
the enzyme shifts completely to the monomeric inactive form
after H2O2 exposure (Fig. 5A). BH4 had no effect on heNOS
dimer levels in the absence of H2O2 (Fig. 5A). However, pre-
incubation with excess BH4 (100mM) protects the dimer levels
from H2O2-induced collapse (Fig. 5A). heNOS activity was
measured in the presence and absence of BH4 and H2O2. Our
results indicate that preincubation of purified heNOS with
BH4 significantly preserved heNOS activity after challenge
by H2O2 (Fig. 5B). To further understand the role of BH4 in
heNOS activity maintenance during acute oxidative stress
induced by H2O2, we measured H2O2 dismutation in the
presence of BH4. Interestingly, we found that BH4 acts as a
catalase mimetic by stimulating the conversion of H2O2 to
H2O by 15-fold (Fig. 6). These data suggest that the BH4 may
exert a dimmer-stabilizing effect due to its antioxidant
capacity.
Finally, we determined whether disruption of the eNOS
dimer could be induced by increased levels of H2O2 in cul-
tured PAECs. PAECs were exposed to H2O2 (100 mM) and
FIG. 5. Increasing BH4 levels decreases the H2O2-mediated heNOS dimer collapse. (A) Representative gel filtration chro-
matograms from three independent experiments. (B) The presence of BH4 prevents dimer collapse induced by H2O2. BH4 also
attenuates the H2O2-mediated inhibition of [
3H]-l-arginine to [3H]-l-citrulline conversion by heNOS. Values are mean SD
from three experiments. *p< 0.05 versus untreated, {p< 0.05 versus no additional BH4.
FIG. 6. BH4 acts as a catalase mimetic. A 10mM H2O2 in
50mM potassium phosphate buffer (pH 7.8) was incubated
in the presence or absence of BH4 (14 mM) and the rate of
conversion of H2O2 to H2O was determined spectrophoto-
metrically at 240 nm (for 30 s). Data are represented as rela-
tive changes from spontaneous H2O2 to H2O conversion;
n¼ 3. *p< 0.05 versus no BH4.
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then LT-PAGE and western blot analysis were performed to
examine the dimeric state of eNOS. The results obtained in-
dicate that there is a significant reduction in the level of di-
meric functional eNOS in H2O2-treated PAECs (Fig. 7A, B)
and a reduction in NO generation in response to laminar
shear stress indicating a loss of enzyme activity (Fig. 7C).
This was also associated with a reduction in cellular BH4
levels (Fig. 7D). Further, we found that if PAECs were pre-
incubated with the BH4 precursor sepiapterin, the eNOS
dimer was protected against H2O2 challenge (Fig. 8 A, B),
and that NO generation was preserved when cells were ex-
posed to laminar shear stress (Fig. 8C).
Discussion
NOS subunit dimerization serves as a point of biochemical
regulation (Ratovitski et al., 1999) and data from Stuehr’s
group indicated that NOS dimerization could be a potential
target for selective control through pharmacologic interven-
tion (Sennequier et al., 1999; Panda et al., 2002). To catalyze
NO formation, eNOS must assemble into a homodimeric
form (Rodriguez-Crespo et al., 1996). However, it is still not
well understood how NOS isoforms dimerize. This is due, at
least in part, to the fact that the complete crystal structure has
not been determined for any NOS isoform. Consequently,
the complete dimer interface of eNOS remains to be eluci-
dated and neither the dimerization of NOS proteins nor the
mechanisms that control the dimer=monomer shift have been
completely elucidated.Onepossiblewayof controllingdimer=
monomer shift is through oxidation of cysteine residues that
are located at dimer interfaces to cysteic acid. Cysteic acid
modifications are a not uncommon modification because an
increasing number of proteins have been shown to be a
target for H2O2-induced cysteine–cysteic acid posttransla-
tional modification. The list of target proteins include human
apoprotein B-100, peroxiredoxins, promatrix metalloprotei-
nases, nitrile hydratases, tubulin, vimentin, phophoglycerate
kinase 1, ATP synthase, enolase nucleophosmin, heat-shock
cognate 54-kDa protein, peroxiredoxin I, glyceraldehyde 3-
phosphate, and hemoglobin HbAo (Murakami et al., 2000; Fu
et al., 2001; Rabilloud et al., 2002; Paron et al., 2004; Jia et al.,
2007). In addition, the data presented here describe, for the
first time, the presence of 11 cysteines within the heNOS se-
quence that are susceptible to oxidation to cysteic acid after
micromolar H2O2 treatment (Table 1). The mass spectra ana-
lyses show that both exposed cysteines 94 and 99 are oxidized
(Table 1). H2O2 can directly oxidize proteins especially if the
pKa of the reactive cysteine is near the acidic range. The local
FIG. 7. H2O2 exposure disrupts the eNOS dimer in ovine PAECs. PAECs were exposed to H2O2 (100 mM) for 15min. Protein
extracts were then prepared and separated on 7.5% polyacrylamide gels using LT-PAGE, electrophoretically transferred to
Hybond membranes, and analyzed using a specific antiserum raised against eNOS. (A) A representative western blot is
shown. (B) The densitometric values demonstrate that H2O2 decreases the level of eNOS dimers in PAECs and decreases the
NO generation (C) in response to laminar shear stress (5min, 20 dyn=cm2). (D) BH4 levels (expressed as pmol=mg protein) are
also decreased in cells exposed to H2O2. Values are mean SD; n¼ 3–6. *p< 0.05 versus untreated. {p< 0.05 versus no H2O2.
PAECs, pulmonary arterial endothelial cells.
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milieu including neighboring amino acids and the binding to
metal moieties play a role in maintaining lower pKa of cys-
teine, making it more susceptible to oxidants. The zinc tetra-
thiolate cysteine in eNOS has a low pKa. Thus, this may
explain why the tetrathiolate zinc can be directly oxidized by
H2O2. The crystal structure of the heme domain of heNOS has
a zinc ion that is tetrahedrally coordinated to two pairs of
symmetry-related cysteine residues (corresponding to cyste-
ines 94 and 99 from each monomer), located at the bottom of
the dimer interface (Crane et al., 1998; Fischmann et al., 1999).
Moreover, cysteine 99 was found to be S-nitrosylated, impli-
cating both cysteine 99 and S-nitrosylation in the regulation of
eNOS dimerization and activity (Taldone et al., 2005). Another
study from our group links the inhibitory action of NO with
the collapse of the zinc tetrathiolate metal-binding site that
maintains and stabilizes the dimeric interface (Ravi et al.,
2004). More recently, we have identified all the potential
cysteine S-nitrosylation sites in heNOS, with 95% of protein
coverage by mass spectrometry analysis (Tummala et al.,
2008). Based on all these data, we suggest that the molecular
mechanism by which H2O2 exerts its inhibitory effect on he-
NOS involves, at least in part, the oxidation of cysteine resi-
dues 94 and 99 within the zinc coordination. In addition, the
MS data show that several other cysteine residues are capable
of undergoing cysteic acid modification after H2O2 treatment.
Cysteines 14 and 25, located at the extreme N-terminus of
heNOS, can be palmitoylated, thereby targeting eNOS from
the golgi apparatus to the plasma membrane where it resides
partially in caveolae. Cysteines 367 and 380, residues that
were predicted to be located within the HSP90 binding site on
heNOS, are also a target for H2O2 oxidation. Moreover, the
cysteine residue 710, located at the flavin mononucleotide
(FMN) binding site, is yet another target for H2O2 oxidation.
Also, we identified cysteine residues 990, 1104, and 1113 as
being susceptible to oxidation by H2O2. These cysteines are
located in regions of heNOS that have not been implicated in
any known biochemical function. Together, these data sug-
gest that H2O2 may regulate heNOS function in many dif-
ferent ways in addition to inducing dimer collapse through
zinc tetrathiolate metal-binding site destruction. Recently,
we have identified the cysteine residues that are targets for
S-nitrosylation within heNOS (Tummala et al., 2008). Inter-
estingly, the cysteines residues 14, 25, 94, 99, 990, and 1113 are
targets for S-nitrosylation and also to cysteic acid modifica-
tion. These results indicate that heNOS activity can be in-
hibited in conditions of high oxidative and nitrosative stress,
through the modification of the same target cysteines. More-
over, it has been shown that peroxinitrite can disrupt the
eNOS zinc metal-binding site through oxidation of the tetra-
thiolate cysteines 94 and 99 (Zou et al., 2002). And, most re-
FIG. 8. Increasing BH4 levels decrease H2O2-mediated reduction in eNOS activity in ovine PAECs. PAECs were treated or
not with the BH4 precursor sepiapterin (100mM) for 18 h and then exposed to H2O2 (100 mM) for 15min. Protein extracts were
then prepared and separated on 7.5% polyacrylamide gels via LT-PAGE, then electrophoretically transferred to Hybond
membranes, and analyzed using a specific antiserum raised against eNOS. (A) A representative western blot is shown. (B) The
densitometric values demonstrate that BH4 reduces the H2O2-mediated decrease in eNOS dimers. Cells were also treated or
not with the BH4 precursor sepiapterin (100mM) for 18 h in the presence or absence of N-acetylserotonin (NAS) (10mM). Cells
were then treated with H2O2 (100mM) for 15min and then exposed to laminar shear stress (20 dyn=cm
2) for 5min. Results are
presented as a percentage of NOx release from sheared cells not exposed to H2O2 or sepiapterin. Addition of sepiapterin
increases NO production by PAECs both in the presence and absence of H2O2 (C). Data are mean SD; n¼ 6. *p< 0.05 versus
sheared alone, {p< 0.05 versus H2O2 alone.
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cently, Xu et al. (2006) demonstrated that hypochlorous acid
treatment lead to zinc release by eNOS. Based on these data
we now suggest that eNOS monomerization can be consid-
ered as a general inhibitory mechanism in response to oxi-
dative and nitrosative stress. It is also worth noting that we
have minor discrepancies in our data evaluating eNOS dimer
levels using LT-PAGE in conjunction with western blotting
and gel filtration. Although gel filtration analysis indicated
total dimer collapse, we could still detect some residual eNOS
dimer using western blotting. This is likely due to the fact that
western blotting is a much more sensitive method compared
with gel filtration. In general, antibodies are capable of de-
tecting pico- to femtogram quantities of protein, and thus,
even though the dimer amount in western blotting is very
low, it will be detected. Conversely, dimer detection using gel
filtration is based on absorbance at 280 nm and is therefore
less sensitive.
Based on the distance criteria of 2.5 A˚ for a true H-bond,
we built a three-dimensional model of the zinc tetrathiolate
cluster. Our model predicts that the zinc coordination is
maintained by four symmetrical intramolecular van der
Waals interactions between the cysteines 94 and 99. These
intramolecular forces hold the zinc atom in the tetrahedral
atomic configuration. Additionally, a network of H-bonds
between cysteines 94 and 99 and residues L100, G101, and
N466 guarantees perfect symmetrical configuration of these
cysteines within the zinc coordination. Figure 1B illustrates
the molecular modeling prediction of the effects caused by
cysteic acid formation within the zinc metal-binding site. The
zinc coordination is destroyed in the presence of H2O2. Cy-
steine 99 from both chains on the heNOS dimer has a H-bond
distance of 2.37 A˚ from G101. Consequently, serine 102 from
both chains relies on the integrity of zinc coordination to be
in perfect H-bond distance from the BH4 pocket. Thus, we
cannot rule out the possibility that cysteic acid modification
of cysteines 94 and 99 may also alter the BH4-binding pocket
leading to decreased BH4, l-arginine affinity, and=or heme
distortion=loss and further studies will be required to test
these possibilities.
Confirming the MS data and the molecular modeling
predictions, our in vitro activity assay data show that H2O2
inhibits the l-arginine to citrulline conversion by heNOS.
Moreover, the inhibition of heNOS activity by H2O2 corre-
lates with dimer collapse and loss of zinc from the enzyme.
However, there is a contradiction in the literature regarding
zinc binding: Some reports have suggested that an intact zinc
tetrathiolate metal-binding site is not obligatory for NOS
dimerization (Rodriguez-Crespo et al., 1997; Martasek et al.,
1998; Ghosh et al., 1999). In addition, Adak et al. (2002) have
generated a NOS mutant lacking the N-terminal zinc-bind-
ing sequence, and interestingly, the enzyme was dimeric.
Conversely, it has been suggested that an intact zinc tetra-
thiolate metal-binding site is essential for formation of so-
dium dodecyl sulfate (SDS)-resistant NOS dimers but is not
essential for catalysis (Hemmens et al., 2000). In addition, it
has been shown that zinc content is influenced by cellular
pterin levels and that zinc plays a structural, rather than a
catalytic, role in maintaining enzymatically active constitu-
tive NOS (Miller et al., 1999). However, Ravi et al. (2004) have
demonstrated that S-nitrosylation of cysteines 94=99 leads to
the disruption of zinc coordination, heNOS monomerization,
and activity loss. Based on these data and our modeling
predictions, we propose that the molecular mechanism by
which H2O2 induces zinc release involves the oxidation of the
tetrathiolate cysteines 94 and 99, and consequently the dis-
ruption of van der Waals interactions at the bottom of the
dimer interface. Further, our studies in cultured PAECs
confirmed that H2O2 challenge could also induce eNOS di-
mer collapse and a decrease in NOS activity, indicating that
the data generated using recombinant heNOS are not limited
to an in vitro situation.
Previous studies have indicated that BH4 is involved in an
extensive H-bond network which stabilizes the eNOS dimer
(Raman et al., 1998), whereas our HPLC analysis data dem-
onstrated that after challenge with a pathophysiological
concentration H2O2 the predominant pterin form bound to
heNOS is BH2. Thus, it is possible that if BH4 stabilizes the
heNOS dimer, oxidation of BH4 could in turn lead to the
distortion of the BH4-binding pocket and consequently
helping to promote dimer collapse. Interestingly, BH4 sup-
plementation does protect heNOS dimer against H2O2 attack
both in vitro and in vivo. However, pterins, such as BH4, have
been shown to have antioxidant activity (Kurobane et al.,
1995) and we found that the action of BH4 resembles that of a
catalase mimetic. Therefore, we suggest that BH4 can protect
heNOS dimer disruption by its intrinsic antioxidant capacity
that prevents the oxidation of the tetrathiolate cysteines 94=99
rather than through a direct effect on stabilizing the eNOS
dimer itself. Indeed, recombinant enzyme expression experi-
ments (Tzeng et al., 1995; Reif et al., 1999) and endothelial cell
culture studies (Cai et al., 2002) have found that BH4 promotes
eNOS dimerization, protein stability, andNO synthesis. Thus,
BH4 appears to have independent, but complementary, roles
in regulating eNOS activity. BH4may be involved in the direct
physical stabilization of heNOS in its active dimeric form
while also participating in catalytic activity by donating
electrons to the ferrous–dioxygen complex in the oxygenase
domain as the initiating step of the l-arginine to citrulline
conversion (Wei et al., 2008). Finally, BH4, because of its in-
trinsic antioxidant capacity (catalase mimetic), can protect the
cysteines 94 and 99 by preventing their oxidation upon an
acute oxidative stress.
Together, our results delineate the molecular mechanism
by which H2O2 promotes dimer collapse and activity loss.
This mechanism implicates both oxidation of the cysteines 94
and 99 to cysteic acid within the zinc tetrathiolate metal-
binding site and the oxidation of BH4. We further speculate
that dimer collapse may be an important regulatory mech-
anism under conditions of acute oxidative stress where NO
bioavailability is decreased.
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